Status:
ACTIVE_NOT_RECRUITING
Real World and Epidemiology Study of Medically Attended Chlamydia Trachomatis Among Adults in Germany
Lead Sponsor:
Sanofi
Conditions:
Chlamydia Trachomatis
Eligibility:
All Genders
14-44 years
Brief Summary
This study assesses the epidemiologic situation of chlamydia trachomatis, its complications and long term sequalae and related healthcare resource utilization and costs among adults in Germany. The s...
Eligibility Criteria
Inclusion
- Either male or female is documented as gender in base data
- At cohort entry, a patient must be aged between 14 and 44 years
Exclusion
- None
Key Trial Info
Start Date :
March 13 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 17 2026
Estimated Enrollment :
81239 Patients enrolled
Trial Details
Trial ID
NCT07002047
Start Date
March 13 2025
End Date
February 17 2026
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Germany, Germany